ACST Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 bal. 2024 @ 23:00):

Acasti Pharma Inc., a biopharmaceutical company, engages in the development and commercialization of pharmaceutical products for cardiovascular diseases...

Stats
Dzisiejszy wolumen	3 820.00
Średni wolumen	25 968.00
Kapitalizacja rynkowa	27.26M
EPS	$-0.300 ( 2024-02-13 )
Następna data zysków	( $-0.350 ) 2024-06-28
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.510
ATR14	$0.0430 (1.48%)

Insider Trading

Date	Person	Action	Amount	type
2024-01-05	Delaversano Robert J	Sell	42 000	Stock Options (Right to Buy)
2023-12-19	Kavuru Vimal	Buy	10 000	Stock Options (Right to Buy)
2023-12-19	Kottayil George	Buy	22 500	Stock Options (Right to Buy)
2023-12-19	Neugeboren Edward	Buy	22 500	Stock Options (Right to Buy)
2023-12-19	Davis A Brian	Buy	22 500	Stock Options (Right to Buy)

INSIDER POWER
88.62
Last 64 transactions
Buy: 4 252 386 \| Sell: 2 858 533

Acasti Pharma Inc Korelacja

10 Najbardziej pozytywne korelacje
RMRM	0.959
IKT	0.947
CRDO	0.926
AGFY	0.92
ELTK	0.916
MRVL	0.906
UCTT	0.904
NTUS	0.902
BLZE	0.901
NWSA	0.9

10 Najbardziej negatywne korelacje
NEXT	-0.895
ECOR	-0.889
HFBL	-0.889
IRTC	-0.887
MTEK	-0.882
HIBB	-0.88
HALL	-0.876
WTFC	-0.876
EYEG	-0.875
MLAB	-0.874

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Acasti Pharma Inc Finanse

Annual	2022
Przychody:	$0
Zysk brutto:	$-52.16M (0.00 %)
EPS:	$-5.71

FY	2022
Przychody:	$0
Zysk brutto:	$-52.16M (0.00 %)
EPS:	$-5.71

FY	2022
Przychody:	$0
Zysk brutto:	$-15.59M (0.00 %)
EPS:	$-0.270

FY	2021
Przychody:	$196 000
Zysk brutto:	$120 000 (61.22 %)
EPS:	$-1.360

Financial Reports:

No articles found.

Acasti Pharma Inc

Acasti Pharma Inc., a biopharmaceutical company, engages in the development and commercialization of pharmaceutical products for cardiovascular diseases. It is evaluating strategic partnerships for the clinical development of CaPre. The company was incorporated in 2002 and is headquartered in Laval, Canada.